Exagen Inc. (XGN)

USD 4.6

(7.98%)

Revenue Summary of Exagen Inc.

  • Exagen Inc.'s latest annual revenue in 2023 was 52.54 Million USD , up 15.33% from previous year.
  • Exagen Inc.'s latest quarterly revenue in 2024 Q2 was 15.06 Million USD , up 4.5% from previous quarter.
  • Exagen Inc. reported a annual revenue of 45.56 Million USD in annual revenue 2022, down -5.66% from previous year.
  • Exagen Inc. reported a annual revenue of 48.29 Million USD in annual revenue 2021, up 15.07% from previous year.
  • Exagen Inc. reported a quarterly revenue of 14.41 Million USD for 2024 Q1, up 4.72% from previous quarter.
  • Exagen Inc. reported a quarterly revenue of 11.23 Million USD for 2023 Q1, down -12.52% from previous quarter.

Annual Revenue Chart of Exagen Inc. (2023 - 2012)

Historical Annual Revenue of Exagen Inc. (2023 - 2012)

Year Revenue Revenue Growth
2023 52.54 Million USD 15.33%
2022 45.56 Million USD -5.66%
2021 48.29 Million USD 15.07%
2020 41.97 Million USD 3.93%
2019 40.38 Million USD 24.5%
2018 32.44 Million USD 21.01%
2017 26.8 Million USD 0.0%
2015 17.94 Million USD 53.87%
2014 11.66 Million USD 281.77%
2013 3.05 Million USD 229.91%
2012 926 Thousand USD 0.0%

Peer Revenue Comparison of Exagen Inc.

Name Revenue Revenue Difference
Aspira Women's Health Inc. 9.15 Million USD -474.044%
bioAffinity Technologies, Inc. 2.53 Million USD -1974.947%
Intelligent Bio Solutions Inc. 3.11 Million USD -1588.679%
Standard BioTools Inc. 106.34 Million USD 50.585%
Inotiv, Inc. 572.42 Million USD 90.82%
Prenetics Global Limited 21.74 Million USD -141.681%
Neuronetics, Inc. 71.34 Million USD 26.35%
Star Equity Holdings, Inc. 45.78 Million USD -14.771%
Castle Biosciences, Inc. 219.78 Million USD 76.092%
Psychemedics Corporation 22.09 Million USD -137.795%
RadNet, Inc. 1.61 Billion USD 96.75%
Exact Sciences Corporation 2.49 Billion USD 97.898%
IDEXX Laboratories, Inc. 3.66 Billion USD 98.565%
iSpecimen Inc. 9.92 Million USD -429.281%
OpGen, Inc. 3.41 Million USD -1437.246%
Bionano Genomics, Inc. 36.11 Million USD -45.498%
CareDx, Inc 280.32 Million USD 81.255%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 312.97 Million USD 83.21%
Guardant Health, Inc. 563.94 Million USD 90.682%
Biodesix, Inc. 49.08 Million USD -7.051%
BioNexus Gene Lab Corp. 9.77 Million USD -437.806%
Precipio, Inc. 15.19 Million USD -245.779%
Natera, Inc. 1.08 Billion USD 95.146%
Fulgent Genetics, Inc. 289.21 Million USD 81.831%
Sera Prognostics, Inc. 306 Thousand USD -17072.549%
23andMe Holding Co. 219.63 Million USD 76.075%
OPKO Health, Inc. 863.49 Million USD 93.914%
Personalis, Inc. 73.48 Million USD 28.488%
Aclaris Therapeutics, Inc. 31.24 Million USD -68.159%
Applied DNA Sciences, Inc. 13.36 Million USD -293.104%
T2 Biosystems, Inc. 7.19 Million USD -630.544%
Neogen Corporation 924.22 Million USD 94.314%
Myriad Genetics, Inc. 678.4 Million USD 92.254%
ICON Public Limited Company 8.12 Billion USD 99.353%
NeoGenomics, Inc. 591.64 Million USD 91.118%
Star Equity Holdings, Inc. 45.78 Million USD -14.771%
MDxHealth SA 70.19 Million USD 25.138%
Prenetics Global Limited 21.74 Million USD -141.681%
Illumina, Inc. 4.5 Billion USD 98.833%
DarioHealth Corp. 20.35 Million USD -158.196%
ENDRA Life Sciences Inc. - USD -Infinity%
Medpace Holdings, Inc. 1.88 Billion USD 97.214%
Mainz Biomed B.V. 895.47 Thousand USD -5768.144%
Trinity Biotech plc 56.83 Million USD 7.538%
Sotera Health Company 1.04 Billion USD 94.992%
bioAffinity Technologies, Inc. 2.53 Million USD -1974.947%